Patent · US Expired

Tubulysin analogues

US7816377B2 · kind B2 · utility

27Cited by

0References

17Claims

0Family size

Assignee

R&D BIOPHARMACEUTICALS GMBH · DE

Inventors

Alexander Dömling · Groningen, NL
Bernd Henkel · Frankfurt am Main, DE
Barbara Beck · Hersbruck, DE
Katrin Illgen · Birkenfeld, DE
Sukumar Sakamuri · San Diego, US
Sanjay Menon · Danbury, US

Key dates

Filing date	Jul 9, 2003
Grant date	Oct 19, 2010
Priority date	—
Expiry date	Jan 8, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to tubulysin derivatives of general formula (II), said derivatives having a cytostatic effect.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.